Toggle navigation
Home
Search
Services
Blog
Contact
About
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A.
Weill Medical College of Cornell University, New York, NY, United States
Search 7 grants from Michelle Lane
Search grants from Weill Medical College of Cornell University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mental Health Services Sciences Development Award
Exercise Rehabilitation of Younger and Older Claudicants
Isolation and Structure of Microsomal Membrane Proteins
Reconstitution of the Postsynaptic 43kd Protein
REU Site: Integrated Biological Sciences Summer Research Program (IBS-SRP)
Recently added grants:
Regulation of intercalated cell function by the mineralocorticoid receptor
Improving Genetic Counseling for BRCA+ Mothers
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
Universal room temperature stable influenza nanovaccine
Surgical Treatment of Cardiac Arrhythmias
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA075722-01A1
Application #
2638266
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-01-22
Project End
Budget Start
1998-08-10
Budget End
1999-08-09
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Related projects
NIH 2000
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
$40,013
NIH 1999
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
NIH 1998
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
Publications
Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al.
(2008)
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.
Mol Cell Endocrinol 280:63-74
Comments
Be the first to comment on Michelle Lane's grant